Immusoft
Immusoft, a biotechnology company, commercializes technologies that program the human immune system by modifying the DNA in related cells. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD155m (Public information from Sep 2020)
Seattle Washington (HQ)
Authorizing premium user...